In vitro activity of fosfomycin tromethamine and linezolid against vancomycin-resistant Enterococcus faecium isolates

被引：3
|
作者：
Cilli, Feriha [1 ]
Pullukcu, Husnu [2 ]
Aydemir, Sohret
Sipahi, Oguz Resat [1 ,2 ]
Tasbakan, Meltem [1 ,2 ]
Turhan, Ajda [1 ]
Ulusoy, Sercan
机构：
[1] Ege Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Izmir, Turkey
[2] Ege Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Izmir, Turkey
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2008年 / 31卷 / 03期
关键词：
D O I：
10.1016/j.ijantimicag.2007.11.003
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：296 / 298
页数：3
相关论文
共 50 条
  • [1] In vitro activity of fosfomycin tromethamine and linezolid against clinical vancomycin-resistant Enterococcus faecium isolates
    Cilli, F.
    Pullukcu, H.
    Aydemir, S.
    Sipahi, O.
    Tasbakan, M.
    Turhan, A.
    Ulusoy, S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S167 - S168
  • [2] In vitro synergy with fosfomycin plus doxycyclin against linezolid and vancomycin-resistant Enterococcus faecium
    Davis, Heather
    Brown, Ryan
    Ashcraft, Deborah
    Pankey, George
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 : 78 - 83
  • [3] Fosfomycin Enhances the Inhibition Ability of Linezolid Against Biofilms of Vancomycin-Resistant Enterococcus faecium in vitro
    Chi, Jie
    Li, Yaowen
    Zhang, Na
    Liu, Huiping
    Chen, Zhifeng
    Li, Jiabin
    Huang, Xiaohui
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 7707 - 7719
  • [4] In vitro susceptibility testing of vancomycin-resistant Enterococcus faecium to fosfomycin
    Mancini, Stefano
    Greiner, Michael
    Egli, Adrian
    Nolte, Oliver
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025,
  • [5] Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates
    Klupp, E. -M.
    Both, A.
    Belmar Campos, C.
    Buettner, H.
    Koenig, C.
    Christopeit, M.
    Christner, M.
    Aepfelbacher, M.
    Rohde, H.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (12) : 1957 - 1961
  • [6] Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates
    E.-M. Klupp
    A. Both
    C. Belmar Campos
    H. Büttner
    C. König
    M. Christopeit
    M. Christner
    M. Aepfelbacher
    H. Rohde
    European Journal of Clinical Microbiology & Infectious Diseases, 2016, 35 : 1957 - 1961
  • [7] In Vitro and In Vivo Studies of Oritavancin and Fosfomycin Synergism against Vancomycin-Resistant Enterococcus faecium
    Lagatolla, Cristina
    Mehat, Jai W.
    La Ragione, Roberto Marcello
    Luzzati, Roberto
    Di Bella, Stefano
    ANTIBIOTICS-BASEL, 2022, 11 (10):
  • [8] Enhancement of Vancomycin Activity by Phenothiazines against Vancomycin-Resistant Enterococcus Faecium in vitro
    Rahbar, Mohammad
    Mehrgan, Hadi
    Hadji-nejad, Sanaz
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 107 (02) : 676 - 679
  • [9] Pharmacodynamics of Linezolid Plus Fosfomycin Against Vancomycin-Resistant Enterococcus faecium in a Hollow Fiber Infection Model
    Wang, Shuaishuai
    Liu, Huiping
    Mao, Jun
    Peng, Yu
    Yan, Yisong
    Li, Yaowen
    Zhang, Na
    Jiang, Lifang
    Liu, Yanyan
    Li, Jiabin
    Huang, Xiaohui
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [10] Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections
    Lagatolla, Cristina
    Milic, Johana
    Imperi, Francesco
    Cervoni, Matteo
    Bressan, Raffaela
    Luzzati, Roberto
    Di Bella, Stefano
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 99 (02)
12345